Rivastigmine Capsules in Patients With Probable Vascular Dementia
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The goal of this research study is to evaluate, in the open-label extension phase, the
effectiveness, tolerability and safety of rivastigmine capsules in males and females between
the ages of 50 and 85 years old with probable vascular dementia.